Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seoul National University Hospital
With
RF medical
Age
20–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Child-Pugh Class A or B
chronic hepatitis B or chronic hepatitis C or liver cirrhosis
presence of recurrent hepatocellular carcinoma (HCC) after locoregional treatment confirmed by pathology or imaging studies including contrast enhanced computed tomography (CT) or magnetic resonance imaging (MRI) according to Liver Imaging Reporting and Data System (LI-RADS) v2018
single lesion less than or equal to 5 cm, or up to 3 lesions, each greater than less than or equal to 3 cm at the time of locoregional treatment
You may not be if
number of recurrent HCCs, equal or more than 3
largest recurrent HCC size over 3 cm
presence of vascular invasion by HCC
platelet count less than 40,000 per mm3 or International Normalized Ratio (INR) prolongation over 50%
presence of extrahepatic metastasis
Clareo Health | Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet Electrodes
